Work

Supplementary Table S1 from CSF1R Inhibition with Chemotherapy Relieves Systemic Immune Suppression in Patients with Metastatic Triple-Negative Breast Cancer and Boosts Anti–PD-1 Efficacy in Transgenic Mammary Tumors